Most up-to-date research on "Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability" to its huge collection of research reports.
Albany, NY -- (SBWIRE) -- 06/23/2014 -- GBI Research, the leading business intelligence provider, has released its latest research: ‘Epilepsy Therapeutics to 2019 in Asia-Pacific Market’, which provides in-depth analysis of epilepsy market within the Asia-Pacific (APAC) market covering the four countries of Australia, China, India and Japan. The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis.
Browse Detail Report With TOC @ http://www.researchmoz.us/epilepsy-therapeutics-in-asia-pacific-markets-to-2019-treatment-options-enhanced-as-novel-next-generation-aeds-show-improved-safety-and-tolerability-report.html
The value of the epilepsy market in the APAC region amounted to an estimated $1.1 billion in 2012 and is expected to register a Compound Annual Growth Rate (CAGR) of 4.7% to reach $1.5 billion by 2019. The key drivers for growth in the APAC market include: high prevalence in China and India, increased market penetration due to improved market access in China and the expected approvals of drugs with novel mechanisms of action which could expand the therapeutic scope.
Conversely, the growth of the market in APAC region could face the restricting influence of prescribing patterns that give preference to older generation drugs and also due to generic competition as a result of key patent expiries.
The report analyzes treatment usage patterns, market characterization, pipeline analysis and key licensing and co-development deals in anti-epileptics in the four APAC markets of Australia, China, India and Japan.
The report includes:
A brief introduction to epilepsy, including disease pathogenesis, risk factors, diagnosis and treatment options
In-depth analysis of major marketed products covering product performance, product life-cycle and a heat map depicting comparative analysis of safety and efficacy parameters
A comprehensive review of the epilepsy pipeline which includes individual analysis of promising late-stage pipeline drugs that are likely to enter the market during the forecast period. The pipeline is analyzed on the basis of Phase distribution, molecule type and molecular target.
Additional clinical trial analysis by Phase, trial size, trial duration and program failure rate for each molecule type and mechanism of action
Multi-scenario forecasts of the epilepsy market from 2012 to 2019 in the four APAC regions
In-depth analysis of licensing and co-development agreements and an overview of key agreements that could impact growth trends
Key drivers and restraints that have had and are expected to have a significant impact upon the market
Browse Reports in Therapeutic Area @ http://www.researchmoz.us/therapeutic-area-market-reports-37.html
Reasons to Buy
The report will enhance your decision-making capability by allowing you to:
Align your product portfolio to markets with high growth potential
Develop market entry and expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth
Devise effective, tailored strategies for each country through the understanding of key drivers and barriers in the anti-epileptic drugs market
Develop key strategic initiatives based upon an understanding of key focus areas and leading companies
Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact: